Abbonarsi

HIV AND THE PLACENTA - 09/09/11

Doi : 10.1016/S0889-8561(05)70010-2 
James Reuben, PhD a, Bang-Ning Lee, PhD a, Edwina J. Popek, DO b
a Transfusion Medicine and Laboratory Immunology, Division of Laboratory Medicine, University of Texas M. D. Anderson Cancer Center (JR, BNL) 
b Department of Pathology, Baylor College of Medicine, Texas Children's Hospital (EJP), Houston, Texas 

Riassunto

The placenta provides nutrients and removes wastes from the fetus through various mechanisms of transfer, diffusion, carrier-mediated transport and active transport, and vesicular transfer.14 In humans the placental barrier is hemochorial (i.e., the placental trophoblast surface is in direct contact with the maternal blood, forming the maternal–fetal interface).

The fertilized ovum implants directly into the maternal endometrium within a week of fertilization. Anchoring villi form at the end of the fourth postmenstrual week. Specialized invasive trophoblasts, at the tips of the cytotrophoblast columns of the anchoring villi, invade maternal spiral arterioles of the endometrium and the inner third of the myometrium. This vascular adaptation is noted as early as 16 days after ovulation.21 Communication between the developing intervillous space surrounding the villi and maternal blood supply is established by day 11 or 12, after ovulation. However, large amounts of maternal blood do not enter into the intervillous space until 8 weeks later.32 The intervillous space, at term, holds approximately 400 to 500 mL of blood.14, 192

The trophoblast is an ectodermal covering of each villus. The villous barrier varies in thickness throughout gestation, initially being composed of syncytiotrophoblast, cytotrophoblast, and connective tissue stroma. Discontinuities begin to form in the syncytiotrophoblast layer at 9 to 12 weeks after menstruation.145 Cytotrophoblast covers 50% only of the villous circumference in the second trimester and diminishes to 20% at term.14 The formation of syncytial knots and vasculosyncytial membranes (VSM) beginning at 18 to 20 weeks gestation brings the fetal capillary in very close approximation to the maternal blood. The percentage of villous surface occupied by VSM varies from 0% at 12 weeks to nearly 30% at term.71 The VSM constitutes the effective metabolic barrier between the fetal and maternal circulations and is composed of syncytiotrophoblast cytoplasm, trophoblast basement membrane, stromal connective tissue, vascular basement membrane, and capillary endothelium (Figure 1). The VSM becomes progressively thinner, measuring 1 to 3 μm at term, finally resulting in fusion of the capillary and trophoblast basement membrane.14

The placental membranes are multilayered, composed of tissues from the inner cell mass (amnion), the trophoblast shell (chorionic mesoderm), with intervening connective tissue from the extraembryonic mesoderm. The chorion of the free membranes (chorion laeve) is intimately attached to the maternal decidua (Figure 2). Decidua, the endometrial stromal fibroblast, under progestational influences becomes apparent by the 28th day after menstruation and completely surrounds the implanted blastocyst. With growth of the gestational sac, there is obliteration of the uterine cavity as a feto-maternal tissue junction is established around the whole conceptus at 17 weeks after menstruation.

The decidua at the base of the placenta comes into direct contact with the invasive fetal trophoblast of the anchoring villi (Figure 3). At this interface there is extensive mingling of fetal and maternal cells. The fetal trophoblast and maternal decidua are partially separated by a layer of fibrinoid. Increased fibrosis and acute or chronic inflammation may be seen with the implantation site particularly within basal villi.71

Hofbauer cells are phagocytic cells of mesenchymal origin found in the stroma of villi, chorion, and amnion. They are present in the villi from the fourth week after ovulation, prior to the development of a bone marrow. They maintain their ability to undergo mitosis and self-replicate, in contrast to bone marrow-derived macrophages. These cells are relatively constant throughout gestation, comprise about 40% of the stromal cells,76 and express the leukocyte antigens, CD4, CD45, CD68, and CD1a.14, 143

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 Address reprint requests to James Reuben, PhD, Transfusion Medicine and Laboratory Immunology, Division of Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030
This work was supported in part by Grants AI 32466 and AI 29131 from the National Institute of Allergy and Infectious Disease, Grant AI 38543 and HD 266 from the National Institute of Child Health and Human Development, and General Clinical Research Center Grant RR00188 from the National Center for Research Resources.


© 1998  W. B. Saunders Company. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 18 - N° 2

P. 371-400 - maggio 1998 Ritorno al numero
Articolo precedente Articolo precedente
  • MATERNAL IMMUNE RESPONSE TO HIV-1 AND PERINATAL TRANSMISSION
  • Alan L. Landay, Joan N. Siegel, Kenneth Rich
| Articolo seguente Articolo seguente
  • IMMUNOLOGY OF HIV INFECTION IN THE FETUS AND NEWBORN
  • André J. Nahmias, Francis K. Lee, Athena Kourtis, Chris Ibegbu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.